Summary

HNY Research projects that the Animal Blood Plasma and Derivatives market size will grow from 1142.3 Million USD in 2025 to 1535.2 Million USD by 2031, at an estimated CAGR of 5.05%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.This report presents a detailed and holistic analysis of the global Animal Blood Plasma and Derivatives market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Animal Blood Plasma and Derivatives manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.

By Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum

By Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Animal Blood Plasma and Derivatives Revenue
1.4 Market Analysis by Type
1.4.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2026-2031
1.4.2 Immunoglobulin
1.4.3 Fibrinogen
1.4.4 Serum Albumin
1.4.5 Fetal Bovine Serum
1.4.6 Thrombin
1.4.7 New Born Calf Serum
1.5 Market by Application
1.5.1 Global Animal Blood Plasma and Derivatives Market Share by Application: 2026-2031
1.5.2 Food & Beverages
1.5.3 Pharmaceuticals
1.5.4 Cosmetics
1.5.5 Feed
1.5.6 Others
1.6 Study Objectives
1.7 Overview of Global Animal Blood Plasma and Derivatives Market
1.7.1 Global Animal Blood Plasma and Derivatives Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Animal Blood Plasma and Derivatives
2.2 Industry Chain Structure of Animal Blood Plasma and Derivatives
3 Market Competition by Manufacturers
3.1 Global Animal Blood Plasma and Derivatives Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Animal Blood Plasma and Derivatives Average Price by Manufacturers (2020-2025)
4 Animal Blood Plasma and Derivatives Regional Market Analysis
4.1 Animal Blood Plasma and Derivatives Production by Regions
4.1.1 Global Animal Blood Plasma and Derivatives Production by Regions (2020-2025)
4.1.2 Global Animal Blood Plasma and Derivatives Revenue by Regions
4.2 Animal Blood Plasma and Derivatives Consumption by Regions
4.3 North America Animal Blood Plasma and Derivatives Market Analysis
4.3.1 North America Animal Blood Plasma and Derivatives Production
4.3.2 North America Animal Blood Plasma and Derivatives Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Animal Blood Plasma and Derivatives Import and Export
4.4 East Asia Animal Blood Plasma and Derivatives Market Analysis
4.4.1 East Asia Animal Blood Plasma and Derivatives Production
4.4.2 East Asia Animal Blood Plasma and Derivatives Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Animal Blood Plasma and Derivatives Import & Export
4.5 Europe Animal Blood Plasma and Derivatives Market Analysis
4.5.1 Europe Animal Blood Plasma and Derivatives Production
4.5.2 Europe Animal Blood Plasma and Derivatives Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Animal Blood Plasma and Derivatives Import & Export
4.6 South Asia Animal Blood Plasma and Derivatives Market Analysis
4.6.1 South Asia Animal Blood Plasma and Derivatives Production
4.6.2 South Asia Animal Blood Plasma and Derivatives Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Animal Blood Plasma and Derivatives Import & Export
4.7 Southeast Asia Animal Blood Plasma and Derivatives Market Analysis
4.7.1 Southeast Asia Animal Blood Plasma and Derivatives Production
4.7.2 Southeast Asia Animal Blood Plasma and Derivatives Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Animal Blood Plasma and Derivatives Import & Export
4.8 Middle East Animal Blood Plasma and Derivatives Market Analysis
4.8.1 Middle East Animal Blood Plasma and Derivatives Production
4.8.2 Middle East Animal Blood Plasma and Derivatives Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Animal Blood Plasma and Derivatives Import & Export
4.9 Africa Animal Blood Plasma and Derivatives Market Analysis
4.9.1 Africa Animal Blood Plasma and Derivatives Production
4.9.2 Africa Animal Blood Plasma and Derivatives Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Animal Blood Plasma and Derivatives Import & Export
4.10 Oceania Animal Blood Plasma and Derivatives Market Analysis
4.10.1 Oceania Animal Blood Plasma and Derivatives Production
4.10.2 Oceania Animal Blood Plasma and Derivatives Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Animal Blood Plasma and Derivatives Import & Export
4.11 South America Animal Blood Plasma and Derivatives Market Analysis
4.11.1 South America Animal Blood Plasma and Derivatives Production
4.11.2 South America Animal Blood Plasma and Derivatives Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Animal Blood Plasma and Derivatives Import & Export
5 Animal Blood Plasma and Derivatives Sales Market by Type (2020-2031)
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2020-2025)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031)
6 Animal Blood Plasma and Derivatives Consumption Market by Application(2020-2031)
6.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2020-2025)
6.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Animal Blood Plasma and Derivatives Business
7.1 Proliant Inc.
7.1.1 Proliant Inc. Company Profile
7.1.2 Proliant Inc. Animal Blood Plasma and Derivatives Product Specification
7.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Thermo Fisher Scientific, Inc. Company Profile
7.2.2 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product Specification
7.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Merck KGaA
7.3.1 Merck KGaA Company Profile
7.3.2 Merck KGaA Animal Blood Plasma and Derivatives Product Specification
7.3.3 Merck KGaA Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Kraeber & Co GmbH
7.4.1 Kraeber & Co GmbH Company Profile
7.4.2 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product Specification
7.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 LAMPIRE Biological Laboratories, Inc.
7.5.1 LAMPIRE Biological Laboratories, Inc. Company Profile
7.5.2 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product Specification
7.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Lake Immunogenics, Inc.
7.6.1 Lake Immunogenics, Inc. Company Profile
7.6.2 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product Specification
7.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Rocky Mountain Biologicals Inc.
7.7.1 Rocky Mountain Biologicals Inc. Company Profile
7.7.2 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product Specification
7.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 ANZCO Foods Ltd.
7.8.1 ANZCO Foods Ltd. Company Profile
7.8.2 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product Specification
7.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Auckland BioSciences Ltd.
7.9.1 Auckland BioSciences Ltd. Company Profile
7.9.2 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product Specification
7.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Bovogen Biologicals Pty Ltd.
7.10.1 Bovogen Biologicals Pty Ltd. Company Profile
7.10.2 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product Specification
7.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Animal Blood Plasma and Derivatives (2026-2031)
8.2 Global Forecasted Revenue of Animal Blood Plasma and Derivatives (2026-2031)
8.3 Global Forecasted Price of Animal Blood Plasma and Derivatives (2020-2031)
8.4 Global Forecasted Production of Animal Blood Plasma and Derivatives by Region (2026-2031)
8.4.1 North America Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.3 Europe Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.7 Africa Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.9 South America Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Animal Blood Plasma and Derivatives Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Animal Blood Plasma and Derivatives by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.2 East Asia Market Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.3 Europe Market Forecasted Consumption of Animal Blood Plasma and Derivatives by Countriy
9.4 South Asia Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.5 Southeast Asia Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.6 Middle East Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.7 Africa Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.8 Oceania Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.9 South America Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
9.10 Rest of the world Forecasted Consumption of Animal Blood Plasma and Derivatives by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer